title: Pharmacokinetic considerations for treatment of bacterial peritonitis during continuous ambulatory peritoneal dialysis.
authors.affiliation: CTMR Saint-Augustin, Department of Nephrology, Hôpital Pellegrin, Bordeaux, France.
authors.forename: J L
authors.initials: JL
authors.lastname: Bouchet
authors.forename: M
authors.initials: M
authors.lastname: Aparicio
authors.forename: G
authors.initials: G
authors.lastname: Vinçon
authors.forename: F
authors.initials: F
authors.lastname: Demotes-Mainard
authors.forename: C
authors.initials: C
authors.lastname: Quentin
authors.forename: J P
authors.initials: JP
authors.lastname: Bourdenx
authors.forename: J
authors.initials: J
authors.lastname: Dupoux
authors.forename: L
authors.initials: L
authors.lastname: Potaux
mesh_terms: D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002439:Cefotaxime / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D005578:Fosfomycin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009070:Moxalactam / Q000493:pharmacokinetics* / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000188:drug therapy*
chemical_list: D005578:Fosfomycin; D002439:Cefotaxime; D009070:Moxalactam